Oyster Point Pharma, Inc. Annual Depreciation, Depletion and Amortization in USD from 2018 to 2021

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Oyster Point Pharma, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from 2018 to 2021.
  • Oyster Point Pharma, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2022 was $74K, a 222% increase year-over-year.
  • Oyster Point Pharma, Inc. annual Depreciation, Depletion and Amortization for 2021 was $141K, a 83.1% increase from 2020.
  • Oyster Point Pharma, Inc. annual Depreciation, Depletion and Amortization for 2020 was $77K, a 305% increase from 2019.
  • Oyster Point Pharma, Inc. annual Depreciation, Depletion and Amortization for 2019 was $19K.
Depreciation, Depletion and Amortization, Annual (USD)
Depreciation, Depletion and Amortization, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $141K +$64K +83.1% Jan 1, 2021 Dec 31, 2021 10-K 2022-02-24
2020 $77K +$58K +305% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 $19K +$19K Jan 1, 2019 Dec 31, 2019 10-K 2021-02-18
2018 $0 Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.